Updates are available Correction dated 2019-02-12
Click to view Correction: https://doi.org/10.1186/s13287-019-1147-7
-
Authors
Hazim, Roni A.
Karumbayaram, Saravanan
Jiang, Mei
Dimashkie, Anupama
Lopes, Vanda S.
Li, Douran
Burgess, Barry L.
Vijayaraj, Preethi
Alva-Ornelas, Jackelyn A.
Zack, Jerome A.
Kohn, Donald B.
Gomperts, Brigitte N.
Pyle, April D.
Lowry, William E.
Williams, David S.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01EY13408)
National Institutes of Health (P30EY00331)
National Institutes of Health (F31EY026805)
National Institutes of Health (R01AR064327)
Esther B. O'Keeffe Foundation
Jean Perkins Foundation
UCLA Eli and Edythe Broad Stem Cell Research Center
- License Information
-
More Information
Article History
Received: 6 May 2017
Revised: 16 August 2017
Accepted: 29 August 2017
First Online: 2 October 2017
Change Date: 12 February 2019
Change Type: Correction
Change Details: The original article [1] contains an error in the legend of Fig 5 whereby the descriptions for panels 5d and 5e are incorrect; as such, the corrected legend can be viewed below with its respective figure images.
Ethics approval and consent to participate
: Written approvals for human skin biopsy procedures and human fibroblast derivation, culture, and experimental use were obtained from the University of California, Los Angeles, Institutional Review Board (IRB Protocol #11-001087) and the University of California, Los Angeles Stem Cell Research Oversight Committee (UCLA ESCRO Protocol #2010-009-07). Written informed consent was obtained from each individual participant. Cells used in this study were derived in a GMP facility at the UCLA David Geffen School of Medicine. Written approvals for the experiments performed in this study were obtained from the UCLA Institute Biosafety Committee (UCLA IBC Protocol # 110.14.1-f) and the Animal Research Committee (UCLA ARC Protocol #2007-151-23G).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
